EVERTACEF S 1.5GM INJECTION "CEFTRIAXONE 1gm. IP + SULBACTAM 500mg. IP

Evertacef S 1.5GM Injection is an injectable ceftriaxone and sulbactam antibiotic for susceptible bacterial infections. Main uses: lower respiratory tract infections caused by susceptible bacteria; acute bacterial otitis media (middle ear infection) caused by susceptible bacteria; skin and skin structure infections caused by susceptible bacteria; intra-abdominal infections caused by susceptible bacteria; gynaecological infections caused by susceptible bacteria.

Common side effects of Evertacef S 1.5GM Injection include pain, redness, swelling or hardness at the injection site; phlebitis or warmth along the vein after intravenous use; rash; diarrhoea or loose stools; nausea or vomiting; raised liver enzyme levels in blood tests. Get medical help at once if you notice severe allergic reactions, including anaphylaxis; severe skin reactions; pseudomembranous colitis (severe diarrhoea during or after antibiotic use).

Evertacef S 1.5GM Injection contains Ceftriaxone 1 g + Sulbactam 500 mg. Evertacef S 1.5GM Injection is given by a doctor or nurse, who decides the dose and how often it is given.

The MRP of Evertacef S 1.5GM Injection is ₹190 for a pack of 1. For chemists and distributors, the PTR is ₹144.76 and the PTS is ₹130.29.

Evertacef S 1.5GM Injection contains Ceftriaxone 1 g + Sulbactam 500 mg. It comes in a pack of 1.

How it acts is straightforward. Ceftriaxone, a cephalosporin antibiotic, blocks the formation of the bacterial cell wall so the bacteria cannot multiply. Sulbactam works alongside it as a beta-lactamase inhibitor, neutralising the enzymes that some bacteria produce to break down antibiotics and so helping Ceftriaxone remain useful against those bacteria.

Must not be used by anyone with a known allergy to ceftriaxone, sulbactam or any other cephalosporin. Must not be used by anyone with a history of a serious hypersensitivity reaction (such as anaphylaxis or Stevens-Johnson syndrome) to other beta-lactam antibiotics. Must not be used in premature newborn babies up to a post-menstrual age of 41 weeks. Must not be used in newborn babies with high bilirubin (jaundice). Must not be used in newborn babies who need calcium-containing intravenous fluids, and check with a doctor first if you have had an allergy to penicillins, kidney or liver problems, a history of antibiotic-related colitis, or if you are pregnant or breastfeeding.

Evertacef S 1.5GM Injection is a brand of Vibcare Pharma, sold through its Evermed division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.